Brief: Newron Pharmaceuticals SpA Says Roberto Galli Has Been Promoted To Chief Financial Officer As Of July 1, 2023
02/05/2023 12:20
May 2 (Reuters) - Newron Pharmaceuticals SpA NWRN.S :
* NEWRON PHARMACEUTICALS SPA - ROBERTO GALLI HAS BEEN
PROMOTED TO
CHIEF FINANCIAL OFFICER AS OF JULY 1, 2023
Source text for Eikon: ID:nBw7DbWm3a
Further company coverage: NWRN.S
((Reuters.Brief@thomsonreuters.com;))
Recent news on Newron Pharmaceuticals SpA
See all newsUS FDA flags four deaths in Newron's schizophrenia drug studies (updated)
US FDA cites 4 deaths in Newron's schizophrenia drug trial hold
Brief: Newron Says Topline Data From ENIGMA-TRS 1 Expected In Q1 2027
Brief: Newron Provides Update Following Type A Meeting With The FDA
Brief: Newron Reports Pause Of Enrollment Of New Study Participants In US Centers Of ENIGMA-TRS 2 Study